Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H13F3N2O |
| Molecular Weight | 318.2931 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C1=C[C@@H](C2=CC=CC(=C2)C#N)C3=C(CCCC3=O)N1
InChI
InChIKey=RUVMMEREJMHLOS-LBPRGKRZSA-N
InChI=1S/C17H13F3N2O/c18-17(19,20)15-8-12(11-4-1-3-10(7-11)9-21)16-13(22-15)5-2-6-14(16)23/h1,3-4,7-8,12,22H,2,5-6H2/t12-/m0/s1
| Molecular Formula | C17H13F3N2O |
| Molecular Weight | 318.2931 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:45:51 GMT 2023
by
admin
on
Sat Dec 16 18:45:51 GMT 2023
|
| Record UNII |
6J3ZRL30TZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
172649-40-0
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | |||
|
AZD-0947
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | <b>AZD 0947</b> is a potassium channel opener that was under development with AstraZeneca (formed by the merger of Astra and Zeneca in April 1999). It was in??... | ||
|
6J3ZRL30TZ
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | |||
|
9818432
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | |||
|
DTXSID20431296
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | |||
|
ZD-0947
Created by
admin on Sat Dec 16 18:45:51 GMT 2023 , Edited by admin on Sat Dec 16 18:45:51 GMT 2023
|
PRIMARY | AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder. As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company?s development pipeline. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> ACTIVATOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
